140 related articles for article (PubMed ID: 21319990)
1. Prostate cancer proteomics.
Masters JR
OMICS; 2011 Mar; 15(3):169-71. PubMed ID: 21319990
[TBL] [Abstract][Full Text] [Related]
2. The role of proteomics in prostate cancer research: biomarker discovery and validation.
Pin E; Fredolini C; Petricoin EF
Clin Biochem; 2013 Apr; 46(6):524-38. PubMed ID: 23266295
[TBL] [Abstract][Full Text] [Related]
3. Urinary markers for prostate cancer.
Downes MR; Byrne JC; Pennington SR; Dunn MJ; Fitzpatrick JM; Watson RW
BJU Int; 2007 Feb; 99(2):263-8. PubMed ID: 17092277
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of Outcome in Patients With Localized Prostate Cancer Treated With Radiotherapy.
Hall WA; Lawton CA; Jani AB; Pollack A; Feng FY
Semin Radiat Oncol; 2017 Jan; 27(1):11-20. PubMed ID: 27986207
[TBL] [Abstract][Full Text] [Related]
5. Innovative biomarkers for prostate cancer early diagnosis and progression.
You J; Cozzi P; Walsh B; Willcox M; Kearsley J; Russell P; Li Y
Crit Rev Oncol Hematol; 2010 Jan; 73(1):10-22. PubMed ID: 19328712
[TBL] [Abstract][Full Text] [Related]
6. Application of proteomic technologies for prostate cancer detection, prognosis, and tailored therapy.
Fredolini C; Liotta LA; Petricoin EF
Crit Rev Clin Lab Sci; 2010; 47(3):125-38. PubMed ID: 20858067
[TBL] [Abstract][Full Text] [Related]
7. Clinical applications of expression profiling and proteomics in prostate cancer.
Masters JR
Anticancer Res; 2007; 27(3A):1273-6. PubMed ID: 17593619
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer proteomics: Current trends and future perspectives for biomarker discovery.
Tanase CP; Codrici E; Popescu ID; Mihai S; Enciu AM; Necula LG; Preda A; Ismail G; Albulescu R
Oncotarget; 2017 Mar; 8(11):18497-18512. PubMed ID: 28061466
[TBL] [Abstract][Full Text] [Related]
9. In silico verification and parallel reaction monitoring prevalidation of potential prostate cancer biomarkers.
Adeola HA; Calder B; Soares NC; Kaestner L; Blackburn JM; Zerbini LF
Future Oncol; 2016 Jan; 12(1):43-57. PubMed ID: 26615920
[TBL] [Abstract][Full Text] [Related]
10. Mass Spectrometry-Based Glycoproteomics and Prostate Cancer.
Gabriele C; Prestagiacomo LE; Cuda G; Gaspari M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069262
[TBL] [Abstract][Full Text] [Related]
11. Application of proteomic strategies to the identification of urinary biomarkers for prostate cancer: a review.
Downes MR; Byrne JC; Dunn MJ; Fitzpatrick JM; Watson RW; Pennington SR
Biomarkers; 2006; 11(5):406-16. PubMed ID: 16966158
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in urinary proteome analysis for prostate cancer diagnosis and management.
Frantzi M; Latosinska A; Merseburger AS; Mischak H
Expert Rev Mol Diagn; 2015; 15(12):1539-54. PubMed ID: 26491818
[TBL] [Abstract][Full Text] [Related]
13. Proteomics of human prostate cancer biospecimens: the global, systems-wide perspective for protein markers with potential clinical utility.
Garbis SD; Townsend PA
Expert Rev Proteomics; 2013 Aug; 10(4):337-54. PubMed ID: 23992417
[TBL] [Abstract][Full Text] [Related]
14. [Molecular-targeted therapy for prostate cancer].
Miyake H; Fujisawa M
Nihon Rinsho; 2016 Jan; 74(1):2-5. PubMed ID: 26793871
[No Abstract] [Full Text] [Related]
15. Markers of bone metabolism in prostate cancer.
Smith MR
Cancer Treat Rev; 2006; 32 Suppl 1():23-6. PubMed ID: 16680835
[TBL] [Abstract][Full Text] [Related]
16. Discovery of serum protein biomarkers for prostate cancer progression by proteomic analysis.
Al-Ruwaili JA; Larkin SE; Zeidan BA; Taylor MG; Adra CN; Aukim-Hastie CL; Townsend PA
Cancer Genomics Proteomics; 2010; 7(2):93-103. PubMed ID: 20335524
[TBL] [Abstract][Full Text] [Related]
17. Proteomics for the identification of new prostate cancer biomarkers.
Ornstein DK; Tyson DR
Urol Oncol; 2006; 24(3):231-6. PubMed ID: 16678055
[TBL] [Abstract][Full Text] [Related]
18. [Non-invasive diagnosis of prostate cancer: serum and urine markers].
Rubio-Briones J; Casanova-Casas I; Fernández-Serra A; Casanova Ramón-Borja J; Ramírez Backhaus M; Collado Sierra A; Domínguez-Escrig J; Gómez-Ferrer A; López-Guerrero JA
Arch Esp Urol; 2013 Jun; 66(5):440-52. PubMed ID: 23793762
[TBL] [Abstract][Full Text] [Related]
19. [Primary candidate rna biomarker screening by RNA-seq for prostate cancer diagnostics].
Nikitina AS; Babenko VV; Babalyan KA; Vasiliev AO; Govorov AV; Prilepskaya EA; Danilenko SA; Selezneva OV; Sharova EI
Biomed Khim; 2015; 61(6):781-4. PubMed ID: 26716753
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing indolent from aggressive prostate cancer.
Culig Z
Recent Results Cancer Res; 2014; 202():141-7. PubMed ID: 24531788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
